Diabetes Metab J.
2022 Sep;46(5):817-818. 10.4093/dmj.2022.0295.
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
- 2Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 3Department of Preventive Medicine and Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA
- 4Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2533651
- DOI: http://doi.org/10.4093/dmj.2022.0295
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Diagnosis and treatment of dyslipidemia in children and adolescents
- Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines
- New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
- Diabetogenic Effect of Statins: A Double-Edged Sword?
- Effects of Statins for Primary Prevention in the Elderly: Recent Evidence
